GF Fund Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.3K Hold
2,375
﹤0.01% 392
2025
Q1
$79.7K Buy
2,375
+428
+22% +$14.4K ﹤0.01% 380
2024
Q4
$99.6K Buy
+1,947
New +$99.6K ﹤0.01% 333